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Summary
Faithful chromosome segregation is required for cell and
organism viability and relies on both the mitotic checkpoint
and the machinery that corrects kinetochore-microtubule
(k-MT) attachment errors [1–3]. Most solid tumors have
aneuploid karyotypes and many missegregate chromo-
somes at high rates in a phenomenon called chromosomal
instability (CIN) [4–6]. Mad2 is essential for mitotic check-
point function and is frequently overexpressed in human
tumors that are CIN [1, 7–13]. For unknown reasons, cells
overexpressing Mad2 display high rates of lagging chromo-
somes [14, 15]. Here, we explore this phenomenon and
show that k-MT attachments are hyperstabilized by Mad2
overexpression and that this undermines the efficiency of
correction of k-MT attachment errors. Mad2 affects k-MT
attachment stability independently of the mitotic checkpoint
because k-MT attachments are unaltered upon Mad1 deple-
tion and Mad2 overexpression hyperstabilizes k-MT attach-
ments in Mad1-deficient cells. Mad2 mediates these effects
with Cdc20 by altering the centromeric localization and
activity of Aurora B kinase, a known regulator of k-MT attach-
ment stability. These data reveal a new function for Mad2 to
stabilize k-MT attachments independent of the checkpoint
and explain why Mad2 overexpression increases chromo-
some missegregation to cause chromosomal instability in
human tumors.
Results
Many human tumors that are aneuploid and display chromo-
somal instability (CIN) overexpress the conserved checkpoint
protein Mad2 [7–13]. Moreover, mice engineered to overex-
press Mad2 develop tumors that are CIN [14, 15]. Interestingly,
cells derived from mouse models overexpressing Mad2
display elevated frequencies of lagging chromosomes in
anaphase [14, 15], raising the possibility that Mad2 plays a
role as a component of the machinery that regulates kineto-
chore-microtubule (k-MT) attachment stability to promote
the correction of attachment errors needed for faithful chro-
mosome segregation. To determine whether Mad2 influences
the stability of k-MT attachments duringmitosis, wemeasured
the dynamics of k-MTs in cells expressing photoactivatable
GFP-tubulin (PA-GFP-tubulin). We expressed PA-GFP-tubulin
in nontransformed, diploid, chromosomally stable human
RPE-1 cells and used fluorescence dissipation after photoac-
tivation of spindle microtubules to determine the stability of
k-MT attachments (Figure 1A) [3, 16, 17]. Fluorescence decay*Correspondence: duane.a.compton@dartmouth.eduof the activated region fit a double exponential curve (r2 > 0.99)
where the rapidly decaying fluorescence corresponds to non-
k-MTs and the slowly decaying fluorescence corresponds to
k-MTs (Figure 1B). Non-k-MTs turn over with a half-life (t1/2)
of approximately 14.4 6 0.1 s in prometaphase and 15.6 6
0.1 s in metaphase, and there was no detectable change in
these rates in any of our experimental conditions. K-MTs are
more stable during mitosis and display t1/2 of 1.8 6 0.6 min
and 3.8 6 1.1 min in prometaphase and metaphase, respec-
tively, in untreated RPE-1 cells (Figure 2).
Next, we examined k-MT attachment stability in cells
depleted of the conserved checkpoint protein Mad2. Mad2
depletion was confirmed by immunoblot and by reductions
in the mitotic index of cells in the presence of the microtubule
perturbing drug nocodazole indicating functional loss of
checkpoint activity (see Figure S1 available online). To prevent
premature anaphase onset caused by the absence of a
functional mitotic checkpoint in the absence of Mad2, we
measured k-MT turnover in Mad2-deficient mitotic cells
treated with the proteasome inhibitor MG-132 (5 mM). Delaying
anaphase onset using MG-132 does not significantly change
k-MT stability relative to control cells in either prometaphase
or metaphase (Figure 2) regardless of the length of time that
cells were blocked in metaphase (we tested up to 4 hr). The
half-life of k-MT attachments in Mad2-deficient cells was
significantly reduced relative to control cells in both prometa-
phase and metaphase (Figure 2). To eliminate potential off-
target effects of the small interfering RNA (siRNA), we depleted
Mad2 using an siRNA sequence derived from the 30 untrans-
lated region (UTR) and rescued the loss ofMad2 by exogenous
expression of mCherry-Mad2 (Figure S1). Mad2 depletion
using this siRNA sequence was confirmed by immunoblot
and loss of checkpoint function in the presence of nocodazole
(Figure S1). The half-life of k-MT attachments in cells depleted
of Mad2 using this siRNA sequence was reduced compared to
control cells to an extent that was equivalent to cells depleted
with the other siRNA sequence (Figure S1). Overexpression of
mCherry-Mad2 in theseMad2-deficient cells restored both the
checkpoint function and k-MT stabililty indicating a specific
requirement for Mad2 to regulate k-MT attachment stability.
To determine whether the change in k-MT attachment
stability was accounted for by loss of checkpoint activity, we
measured k-MT turnover in cells depleted of another con-
served checkpoint protein: Mad1. Mad1 depletion was con-
firmed by immunoblot and by reductions in the mitotic index
of cells in the presence of the microtubule perturbing drug
nocodazole indicating functional loss of checkpoint activity
(Figure S1). In contrast to Mad2-deficient cells, there was no
significant change in the half-life of k-MT attachments in
Mad1-deficient cells in either prometaphase or metaphase
relative to control cells (Figure 2). This demonstrates that
Mad2 stabilizes k-MT attachments during both prometaphase
and metaphase independently of Mad1.
We next tested the contribution of other proteins involved
in the metaphase-anaphase transition to k-MT attachment
stability by depleting cells of either BubR1 or Cdc20. We
confirmed efficient depletion of BubR1 by immunoblot and
by reductions in the mitotic index of cells in the presence of
Figure 1. Measurement of Kinetochore-Microtubule Dynamics in Cells Overexpressing Mad2
(A) DIC and time-lapse fluorescent images of prometaphase and metaphase spindles in untreated (control) andMad2 overexpression (Mad2 OX) in PA-GFP
tubulin expressing RPE1 cells before (pre-PA) and at indicated times after photoactivation. Mad2 overexpression is visualized by mCherry fluorescence.
(B) Normalized fluorescence intensity over time after photoactivation of spindles in untreated (white circles) and Mad2 OX (filled circles) in prometaphase
and metaphase cells. Data represents mean 6 SEM, nR 10 cells.
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tional loss of checkpoint activity (Figure S1). BubR1 has
a known role in stabilizing k-MT attachments [18–20]. Accord-
ingly, we observed significant reductions in the half-life of
k-MT attachments in BubR1-deficient cells in both prometa-
phase and metaphase (Figure 2). K-MTs in cells simulta-
neously depleted of both Mad2 and BubR1 are significantly
less stable than cells depleted of BubR1 alone in both pro-
metaphase and metaphase (Student’s t test; p = 0.04 in prom-
etaphase, p = 0.02 in metaphase) demonstrating that BubR1
and Mad2 contribute to the stabilization of k-MTs through
independent pathways (Figure 2). The depletion of Cdc20
was confirmed by immunoblot and by increases in mitotic
index indicating a failure to efficiently activate the APC/C to
induce anaphase onset (Figure S1). The half-life of k-MT
attachments in Cdc20-deficient mitotic cells was significantly
reduced relative to control cells in both prometaphase and
metaphase (Figure 2), yet indistinguishable from cells lack-
ing Mad2 alone. The half-life of k-MT attachments in cells
depleted of both Cdc20 and Mad2 in both prometaphaseand metaphase was not significantly different from cells
depleted of either Cdc20 or Mad2 alone (Figure 2; Figure S1)
demonstrating that Mad2 and Cdc20 act in the same pathway
to stabilize k-MT attachments during mitosis.
To test whether excess levels of Mad2 hyperstabilize k-MT
attachments, we overexpressed Mad2 and measured k-MT
attachment stability. Transient expression of mCherry-Mad2
was detected by immunoblot and fluorescence imaging in
most cells (Figure S2). As expected, it localized to kineto-
chores in prometaphase cells (Figure S2). The expression level
of mCherry-Mad2 under these conditions was estimated to be
approximately 5- to 10-fold higher than endogenous protein
levels. There was little change in the mitotic index of cells
overexpressing mCherry-Mad2 consistent with only a 2-fold
increase in time spent between prometaphase and anaphase
measured previously in mouse cells overexpressing Mad2
[14]. The attachment stability of k-MTs in cells overexpressing
mCherry-Mad2 was significantly increased compared to
control cells in both prometaphase and metaphase (Figures
1A and 2). We next tested the effects of overexpression of
Figure 2. Kinetochore-Microtubule Half-Life
k-MT half-life calculated from the exponential decay curve of photoactivated fluorescence (r2 > 0.99) under different conditions for prometaphase (A) and
metaphase (B). Error bars represent SD, *p < 0.05, t test, n = 10–20 cells.
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640mutant versions of Mad2 including mCherry-Mad2DC,
-Mad2V193N, and -Mad2R133A [21, 22]. The level of overex-
pression of each protein was equivalent to mCherry-Mad2
(Figure S2). Neither Mad2DC nor Mad2V193N altered k-MT
attachment stability, indicating that Mad2 must be capable
of converting to a closed conformation to influence k-MT
attachments (Figure 2). In contrast, Mad2R133A stabilized
k-MT attachments, indicating that Mad2 does not need to
dimerize to influence k-MT attachments (Figure 2). Finally, to
test whether k-MT stabilization by excess Mad2 requires
a functional mitotic checkpoint, we overexpressed mCherry-
Mad2 in Mad1-deficient cells. Immunoblot analyses verify
the overexpression of mCherry-Mad2 and the efficient deple-
tion of Mad1 (Figure S1). Overexpression of mCherry-Mad2
increased the half-life of k-MT attachments to similar extents
in mitotic cells with or without Mad1 (Figure 2). Thus, overex-
pression of Mad2 hyperstabilizes k-MT attachments througha mechanism that is independent of the Mad1-dependent
mitotic checkpoint.
The consequence of increasing k-MT attachment stability
is reduced correction of k-MT attachment errors such as
merotely that manifest as lagging chromosomes in anaphase
[3, 5, 6, 23]. Overexpression of mCherry-Mad2 significantly
increases the frequency of anaphase cells with lagging
chromosomes in human RPE-1 cells (Figures 3A and 3B).
Overexpression of mCherry-Mad2DC does not alter the
frequency of lagging chromosomes in anaphase (Figure 3B)
consistent with the lack of change in k-MT attachment stability
when this mutant version of Mad2 is overexpressed. To verify
that the hyperstabilization of k-MT attachments induced by
Mad2 overexpression is the root cause of lagging chromo-
somes in anaphase, we overexpressed the kinesin-13 protein
mitotic centromere-associated kinesin (MCAK), which has
been demonstrated to destabilize k-MT attachments [3]. The
Figure 3. MCAK Overexpression Suppresses Lagging Chromosomes in
Anaphase in Mad2 Overexpressing Cells
(A) Anaphase in RPE-1 cells expressing mCherry-Mad2 (red) alone or both
mCherry-Mad2 and GFP-MCAK (green) and stained for DNA (blue). The
lagging chromosomes induced by Mad2 overexpression are highlighted
by an arrow. Scale bar represents 5 mm.
(B) Number of anaphases with lagging chromosomes in untreated
RPE-1 cells (control) and RPE-1 cells overexpressing mCherry-Mad2
(Mad2 OX), mCherry-Mad2DC (Mad2DC OX), mCherry-Mad2 and GFP-
MCAK (Mad2 OX + MCAK OX), and mCherry-Mad2DC and GFP-MCAK
(Mad2DC OX + MCAK OX). Error bars represent mean 6 SEM, *p < 0.05,
t test, n = 300 cells of three experiments.
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expressing both Mad2 and MCAK was much lower than cells
expressing Mad2 alone and not significantly different from
untreated cells (Figures 3A and 3B). Similar results were ob-
tained using U2OS cells that are aneuploid and CIN and have
an inherently high basal rate of lagging chromosomes in
anaphase owing to CIN (Figure S3). Thus, Mad2 overexpres-
sion undermines the correction of k-MT attachment errors by
hyperstabilizing k-MT attachments. This elevates chromo-
some missegregation rates through the most common mech-
anism known to cause CIN in human tumor cells.
To explore the mechanism through which Mad2 stabilizes
k-MT attachments, we examined the localization of Aurora B
andBubR1, two known regulators of k-MT attachment stability
[18–20, 23–25]. The quantity of Aurora B localized to centro-
meres was significantly increased by Mad2 depletion and
significantly decreased by Mad2 overexpression in both
prometaphase and metaphase (Figures 4A and 4B). The func-
tional activity of Aurora B was similarly influenced by Mad2
levels as judged by alterations in the quantities of Aurora B
substrates CenpA (Figure 4C) [26] and histone H3 (data not
shown). Mad2 levels also affect the quantity and activity ofAurora B kinase at centromeres in nocodazole-treated mitotic
cells (Figure S4) indicating that these events are independent
of microtubule attachment at kinetochores. Moreover, sister
kinetochore spacing was unchanged in both prometaphase
and metaphase by either overexpression or depletion of
Mad2 indicating that Aurora B activity is regulated indepen-
dently of the spatial positioning of sister kinetochores under
these conditions. In contrast, changing Mad2 levels did not
significantly affect the quantity of BubR1 localized at kineto-
chores indicating a specific response of Aurora B to Mad2
levels (Figure 4D). It has been shown that k-MT attachment
stability is acutely sensitive to Aurora B function [23, 27], and
these data demonstrate that Mad2 attenuates the degree to
which Aurora B kinase destabilizes k-MT attachment stability.
Discussion
Combined, these data demonstrate that Mad2 stabilizes k-MT
attachments in mammalian cells. This new function of Mad2 is
independent of the spindle assembly checkpoint because it
acts in both prometaphase and metaphase and does not rely
on Mad1. Mad2 protein levels in mitotic cells exceed those
of Mad1 by approximately 10-fold [28]. Thus, soluble pools
of Mad2 are available for checkpoint-independent functions
if Mad1 limits the quantity of Mad2 entering the checkpoint
signaling pathway. These data support a model whereby
Mad2 stabilizes k-MT attachments independently of targeting
to kinetochores. A soluble pool of Mad2 alters the quantity and
activity of Aurora B kinase at centromeres to influence k-MT
attachment stability (Figure 4E). The conversion of Mad2
from the open to closed conformation is necessary for this
new function, indicating that a fraction of Mad2 undergoes
that conformational switch in the cytosol. The conformational
change in this cytosolic fraction of Mad2 may be induced
through interactions with Cdc20 as suggested previously [21,
22, 29] without targeting to the kinetochore. Evidence support-
ing this view comes from our data showing that Mad2 and
Cdc20 appear to be acting in the same pathway to influence
k-MT stability and other work showing that Mad2-Cdc20
complexes exist independently of the checkpoint-generated
mitotic-checkpoint complex [30, 31], that Mad2 and Cdc20
can form a complex in the absence of functional kinetochores
[30, 32], and that the Mad2-Cdc20 complex persists in meta-
phase cells that lack the mitotic-checkpoint complex [33].
This new function for Mad2 may be related to how it promotes
the reorientation of misaligned chromosomes during meiosis
1 in budding yeast [34].
In addition to Mad2, several other components of the
spindle assembly checkpoint have been implicated in regu-
lating k-MT attachments based on MT density in spindles
[19] or their requirement for efficient chromosome congression
during mitosis [35–39]. Most of these checkpoint proteins
appear to exert their effects by influencing Aurora B kinase
activity. At present, the molecular details for how any of these
checkpoint proteins influence Aurora B activity remains
unknown, but our evidence shows that there are at least two
separate pathways. Because neither Mad2 nor CDC20 coloc-
alize with Aurora B at centromeres, there must be molecular
intermediates in this pathway (Figure 4E), and one candidate
is the centromeric protein Sgo2 that has recently been shown
to bind Mad2 [40]. Finally, we show that overexpression of
Mad2 hyperstabilizes k-MT attachments (Figure 4E), which
impairs the correction of k-MT attachment errors such as
merotely. This is consistent with data showing that many
Figure 4. Mad2AffectsAuroraBLocalizationandActivityat theCentromeres
(A) Metaphase of untreated RPE-1 cells (control) and RPE-1 cells overex-
pressing Mad2 (Mad2 OX) and depleted of Mad2 (Mad2 KD). Scale bar
represents 5 mm.
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persistence of k-MT attachment errors is the root cause of
CIN in most human tumor cells [2, 6]. Thus, our data provide
a direct explanation for the prevalence of CIN in tumor cells




Plasmid transfections were done with FuGENE 6 (Roche Diagnostics),
siRNA transfections were conducted using Oligofectamine (Invitrogen),
and siRNA/plasmid cotransfections were done with X-tremeGene siRNA
(Roche Diagnostics). Cells were analyzed 48 hr after transfection by live-
cell imaging, immunofluorescence, or preparation for immunoblots.
RNA duplexes against Mad1 (50- CCAAAGUGCUGCACAUGAG), BubR1 (50-
GUCUCACAGAUUGCUGCCU), Cdc20 (50-CCUGCCGUUACAUUCCUUC),
Mad2 (50-GCGUGGCAUAUAUCCAUCU), and Mad2 30 UTR (50-CAGTATA
GGTAGGGAGATA) were purchased from Applied Biosystems.
Antibodies
Antibodies used in this study were: Mad2 (Bethyl Laboratories), Aurora B
(Novus Biologicals), BubR1 (Abcam), pCenpA (Cell Signaling), human
CREST serum, actin (Seven Hills Bioreagents), and CDC20 (Bethyl Labora-
tories). Secondary antibodies were conjugated to fluorescein isothyocyante
(FITC) and Texas Red (Jackson ImmunoResearch), Cy5 (Invitrogen), and
HRP (Jackson ImmunoResearch). Immunoblots were detected using
Lumiglow (KPL) and BioRad Chemidoc XRL+.
Photoactivation
Images were acquired using Quorum WaveFX-X1 spinning disk confocal
system (Quorum Technologies Inc., Guelph, Canada) equipped with Mosaic
digital mirror for photoactivation (Andor Technology, South Windsor, CT)
and Hamamatsu ImageEM camera (Bridgewater, NJ). Prometaphase and
metaphase cells with bipolar spindleswere identified using differential inter-
ference contrast (DIC) microscopy. Microtubules were locally activated in
one half spindle. Fluorescence images were captured every 15 s for 6 min
with a 1003 1.4 NA oil-immersion objective. DIC microscopy was then
used to verify that bipolar spindle was maintained throughout image
acquisition and that cells did not enter anaphase. To quantify fluorescence
dissipation after photoactivation, we measured pixel intensities within
a 1 mm rectangular area surrounding the region of highest fluorescence
intensity and background subtracted using an equal area from the nonacti-
vated half spindle. The values were corrected for photobleaching by
determining the percentage of fluorescence loss during 6 mins of image
acquisition after photoactivation in the presence of 10 mM taxol. Fluores-
cence values for the first 4 min were normalized to the first time-point after
photoactivation for each cell and the average intensity at each time point
was fit to a double exponential curve A1 3 exp(–k1t)+A2 3 exp(–k2t) using
MatLab (Mathworks) where A1 represents the less stable non-k-MT popula-
tion and A2 the more stable k-MT population with decay rates of k1 and k2,
respectively. The turnover half-life for each process was calculated as
ln2/k for each population of microtubules.
Immunofluorescence Microscopy
Cells were fixed with ice-cold methanol for 15 min, washed with Tris-buff-
ered saline with 5% bovine serum albumin (TBS-BSA) containing 0.5%
Triton X-100 for 5 min, and TBS-BSA for 5 min. Antibodies were diluted(B and C) Fluorescence intensities of centromeres stained for Aurora B (B)
and phosphorylated CenpA (pCenpA) (C) in RPE1 cells normalized using
CREST in both prometaphase and metaphase.
(D) Fluorescence intensity of BubR1 at kinetochores in prometaphase. Error
bars represent mean6 SEM, *p < 0.05, t test, n = 150–200 kinetochore pairs
(15–20 cells) of three experiments.
(E) Model for Mad2 stabilization of k-MTs. Mad2 promotes k-MT stability by
attenuating the destabilizing effect of Aurora B activity on k-MT attach-
ments. The question mark refers to intermediate components of this
pathway that lie between Mad2 and Aurora B that are yet to be identified.
Overexpression of Mad2 excessively suppresses Aurora B activity resulting
in hyperstable k-MT attachments.
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643in TBS-BSA + 0.1% Triton X-100 and coverslips incubated for 1 hr at room
temperature, after which cells were washed with TBS-BSA for 5 min with
shaking. Secondary antibodies were diluted in TBS-BSA + 0.1% Triton
X-100, and coverslips were incubated for 1 hr at room temperature. For
pCenpA, all wash buffers were supplemented with 80 nM okadaic acid
and 40 nM microcystin. Images were acquired with Orca-ER Hamamatsu
cooled CCD camera mounted on an Eclipse TE 2000-E Nikon microscope.
Optican sections of 0.2 mm in the z axis were collected with a plan Apo
60X 1.4 NA oil immersion objective. Iterative restoration was performed
using Phylum Live software (Improvision). Anaphase chromatids were
counted as lagging if they contained centromere staining (using CREST
antibody) in the spindle midzone separated from centromeres at the poles.
For quantitative assessments, cells were incubated for 4 hr with MG132
(5 mM), or nocodazole (100 ng/mL) then fixed and stained for CREST,
DNA, or AuroraB, pCenpA, or BubR1. Pixel intensities for CREST, AuroraB,
pCenpA, and BubR1 staining were measured in approximately 15 regions
over the entire cell. Background fluorescence was subtracted and the ratios
of intensities were calculated and averaged over multiple kinetochores from
multiple mitotic cells (n = 10 cells).
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Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.cub.2012.02.030.
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